Ectopic ULBP2 Is Associated with Decreased NKG2D Expression in CD8<sup>+</sup> T Cells Under T Cell-Modulatory Conditions in a Murine Tumor Model
UL16-binding protein 2 (ULBP2), a ligand for the activating receptor NKG2D, plays a dual role in tumor immunity, promoting immune activation or suppression, depending on the context. To investigate its impact on CD4<sup>+</sup>CD25<sup>+</sup> T cell-targeted immunotherapies,...
Saved in:
| Main Authors: | Yasuhiko Teruya, Kosuke Yamaguchi, Kohei Yamane, Naomi Miyake, Yuji Nakayama, Takafumi Nonaka, Hiroki Chikumi, Akira Yamasaki |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-06-01
|
| Series: | Cells |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2073-4409/14/12/893 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The role of selected NKG2DLs such as MICA, MICB and ULBP4 as potential markers in multiple sclerosis
by: Aleksandra Pogoda-Wesołowska, et al.
Published: (2025-07-01) -
Epigenetic modulation elicits an NK cell-mediated immune response in urothelial carcinoma
by: Himani Kumari, et al.
Published: (2025-06-01) -
Harnessing NKG2D CAR-T cells with radiotherapy: a novel approach for esophageal squamous cell carcinoma treatment
by: Tianyu Liu, et al.
Published: (2025-05-01) -
POTENTIAL USAGE OF NK CELLS AND NKG2D-POSITIVE LYMPHOCYTES AS TARGETS IN THERAPY OF CROHN’S DISEASE
by: E. A. Shulenina, et al.
Published: (2017-08-01) -
AID‐expressing epithelium is protected from oncogenic transformation by an NKG2D surveillance pathway
by: Arantxa Pérez‐García, et al.
Published: (2015-08-01)